Filter
1769
Filtered Results: 1769
Text search:
drug
registration
Featured
Recommendations
139
New Publications
556
Language
Document type
No document type
1113
Studies & Reports
242
Guidelines
198
Manuals
88
Strategic & Response Plan
77
Training Material
18
Fact sheets
16
Situation Updates
9
Resource Platforms
6
Brochures
2
Countries / Regions
India
168
Kenya
63
Uganda
49
Global
47
Ethiopia
45
Tanzania
44
South Africa
42
Sierra Leone
40
Nigeria
40
Bangladesh
39
Ghana
38
Nepal
37
Malawi
34
Western and Central Europe
34
Namibia
31
Myanmar / Burma
31
Liberia
30
Rwanda
26
Africa
26
Ukraine
24
Zambia
22
Latin America and the Carribbean
21
Eastern Europe
19
Zimbabwe
17
Botswana
17
Cambodia
16
Philippines
15
South–East Asia Region
15
Lesotho
14
Asia
13
Indonesia
11
Syria
9
Congo, Democratic Republic of
8
Mozambique
7
Eswatini/ Swaziland
7
West and Central Africa
6
Russia
6
Colombia
5
East and Southern Africa
5
Brazil
5
Pakistan
5
Tajikistan
4
Timor Leste/ East Timor
4
Benin
4
Albania
4
Senegal
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Sri Lanka
4
Georgia
4
South Sudan
4
Cameroon
3
Haiti
3
Venezuela
3
Western Pacific Region
3
Argentina
3
Moldova
3
Sudan
3
Bhutan
3
Iraq
3
North Macedonia
2
Thailand
2
China
2
Chile
2
Iran
2
Laos
2
Burkina Faso
2
Afghanistan
2
Armenia
2
Jordan
2
Germany
2
Paraguay
2
North America
2
Uruguay
2
United Kingdom
2
Bolivia
2
Vietnam
2
Papua New Guinea
2
Angola
2
Libya
2
North Korea
1
Australia
1
Gambia
1
Kazakhstan
1
Fiji
1
Kyrgyzstan
1
Uzbekistan
1
Peru
1
Malaysia
1
Morocco
1
Bulgaria
1
Guinea
1
Italy
1
USA
1
Guinea-Bissau
1
Lithuania
1
Ireland
1
Saudi Arabia
1
Turkmenistan
1
Denmark
1
Maldives
1
Tunisia
1
Belarus
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Greece
1
Central African Republic
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
889
Clinical Guidelines
123
Public Health
82
Key Resources
47
Women & Child Health
45
Pharmacy & Technologies
35
Capacity Building
21
Toolboxes
TB
195
HIV
172
Mental Health
80
AMR
80
Pharmacy
75
NTDs
55
COVID-19
52
NCDs
35
Caregiver
34
Malaria
33
Conflict
27
Refugee
23
Rapid Response
19
Global Health Education
17
Disability
16
Ebola & Marburg
13
Planetary Health
8
Health Financing Toolbox
8
Specific Hazards
7
Natural Hazards
7
Polio
5
Zika
4
Cholera
2
Social Ethics
2
The Social and Behaviour Change Communication (SBCC) Strategy for the Prevention of the Re-establishment of Malaria Transmission in Timor-Leste forms part of the National Strategic Plan (NSP) for 2021–2025. The strategy aims to support Timor-Leste's efforts to sustain malaria elimination by promot...
This UNHCR guidance note provides comprehensive recommendations for the prevention and control of malaria in refugee settings worldwide. Aligned with the WHO Global Technical Strategy for Malaria, it outlines strategies to ensure access to effective prevention, diagnosis and treatment, implement sus...
This document by Medicines for Malaria Venture (MMV) highlights the significant burden of malaria on children worldwide, emphasizing the need for effective prevention, diagnosis, and treatment strategies. It reviews current challenges and progress in combating pediatric malaria, advocating for conti...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
The "Integrated Management of Malaria Training – Health Worker’s Manual" is a practical guide developed by Uganda’s Ministry of Health to train healthcare workers at all levels in the effective diagnosis, treatment, prevention, and management of malaria. It aligns with national malaria treatme...
Implementation reference guide. This Malaria Surveillance Assessment Toolkit implementation reference guide is a comprehensive reference document, as well as a step by-step guide. It aligns and adapts available tools into a single set of standardized tools, which can be used to conduct malaria surve...
Offering additional pre-exposure prophylaxis (PrEP) choices has the potential to increase uptake and effective use of PrEP, and of HIV prevention overall, as it allows people to choose a method that they prefer.
In this guideline, WHO recommends an offering long-acting injectable lenacapavir (LEN...
Safety and efficacy of long-acting injectable lenacapavir as pre-exposure prophylaxis to reduce the risk of HIV acquisition: a systematic review
recommended
New
Guidelines on lenacapavir for HIV prevention and testing strategies for long-acting injectable pre-exposure prophylaxis. Web Annex B
UNAIDS 2018 / Guidance
Guidance for policy-makers, and people living with, at risk of or affected by HIV
Review
www.co-hivandaids.com
Volume 12 Number 4 July 2017
BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc...
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
The Lancet Global Health January 24, 2022
UNAIDS 2016, Reference
HIV care and support taking into account the 2016 WHO consolidated guidelines
The report highlights key trends and developments in laws affecting people living with HIV and key populations in Asia and the Pacific over the five-year period 2014–2019. It updates the legal and policy review conducted in 2016 for UNAIDS, UNDP and the United Nations Economic and Social Commissio...
J Acquir Immune Defic Syndr Volume 78, Supplement 1, August 15, 2018
WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines.
Updated risk rates for hospital admission in patients with non-severe COVID-19
The guidance includes updated risk rates for...
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
